
Isis A. D. Ghali
Examiner (ID: 16206, Phone: (571)272-0595 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611, 1615 |
| Total Applications | 1721 |
| Issued Applications | 502 |
| Pending Applications | 316 |
| Abandoned Applications | 934 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14682103
[patent_doc_number] => 20190240166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => Transdermal Therapeutic System for 5-Aminolevulinic Acid Hydrochloride
[patent_app_type] => utility
[patent_app_number] => 16/388364
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16388364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/388364 | Transdermal Therapeutic System for 5-Aminolevulinic Acid Hydrochloride | Apr 17, 2019 | Abandoned |
Array
(
[id] => 19808324
[patent_doc_number] => 12239683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Synergistic hepatoprotective composition
[patent_app_type] => utility
[patent_app_number] => 17/056394
[patent_app_country] => US
[patent_app_date] => 2019-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 11094
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056394
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056394 | Synergistic hepatoprotective composition | Apr 17, 2019 | Issued |
Array
(
[id] => 14649613
[patent_doc_number] => 20190231935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => Drug Eluting Foams and the Production Thereof
[patent_app_type] => utility
[patent_app_number] => 16/382652
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4900
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382652
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382652 | Drug Eluting Foams and the Production Thereof | Apr 11, 2019 | Pending |
Array
(
[id] => 16703058
[patent_doc_number] => 10952971
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
[patent_app_type] => utility
[patent_app_number] => 16/370478
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7515
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/370478 | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers | Mar 28, 2019 | Issued |
Array
(
[id] => 16555853
[patent_doc_number] => 20210001001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => MICROPATTERNED SILICONE OXYGENATING DRESSING FOR CHRONIC WOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/982696
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982696 | MICROPATTERNED SILICONE OXYGENATING DRESSING FOR CHRONIC WOUNDS | Mar 20, 2019 | Pending |
Array
(
[id] => 16006755
[patent_doc_number] => 10674725
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-06-09
[patent_title] => Herbicidal composition and method for controlling weeds
[patent_app_type] => utility
[patent_app_number] => 16/359791
[patent_app_country] => US
[patent_app_date] => 2019-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11716
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16359791
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/359791 | Herbicidal composition and method for controlling weeds | Mar 19, 2019 | Issued |
Array
(
[id] => 16568994
[patent_doc_number] => 20210008000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING A SILICONE ACRYLIC HYBRID POLYMER
[patent_app_type] => utility
[patent_app_number] => 15/733595
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733595 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING A SILICONE ACRYLIC HYBRID POLYMER | Mar 10, 2019 | Abandoned |
Array
(
[id] => 16555607
[patent_doc_number] => 20210000755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE COMPRISING A SILICONE ACRYLIC HYBRID POLYMER
[patent_app_type] => utility
[patent_app_number] => 16/979572
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979572 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE COMPRISING A SILICONE ACRYLIC HYBRID POLYMER | Mar 10, 2019 | Abandoned |
Array
(
[id] => 16655933
[patent_doc_number] => 20210052569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING NICOTINE AND SILICONE ACRYLIC HYBRID POLYMER
[patent_app_type] => utility
[patent_app_number] => 16/979577
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979577 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING NICOTINE AND SILICONE ACRYLIC HYBRID POLYMER | Mar 10, 2019 | Abandoned |
Array
(
[id] => 16619879
[patent_doc_number] => 20210038532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING A SILICONE ACRYLIC HYBRID POLYMER
[patent_app_type] => utility
[patent_app_number] => 15/733596
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733596
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733596 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING A SILICONE ACRYLIC HYBRID POLYMER | Mar 10, 2019 | Abandoned |
Array
(
[id] => 16296246
[patent_doc_number] => 20200281969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => INHIBITING VIRAL AND BACTERIAL ACTIVITY USING LOW CONCENTRATION HYPOCHLOROUS ACID SOLUTIONS
[patent_app_type] => utility
[patent_app_number] => 16/293551
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293551 | INHIBITING VIRAL AND BACTERIAL ACTIVITY USING LOW CONCENTRATION HYPOCHLOROUS ACID SOLUTIONS | Mar 4, 2019 | Abandoned |
Array
(
[id] => 14497703
[patent_doc_number] => 20190192506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINE
[patent_app_type] => utility
[patent_app_number] => 16/288911
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16288911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/288911 | TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINE | Feb 27, 2019 | Abandoned |
Array
(
[id] => 15321255
[patent_doc_number] => 20200000957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => SOLID DRESSING FOR TREATING WOUNDED TISSUE AND PROCESSES FOR MIXING FIBRINOGEN AND THROMBIN WHILE PRESERVING FIBRIN-FORMING ABILITY, COMPOSITIONS PRODUCED BY THESE PROCESSES, AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/289535
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289535
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289535 | SOLID DRESSING FOR TREATING WOUNDED TISSUE AND PROCESSES FOR MIXING FIBRINOGEN AND THROMBIN WHILE PRESERVING FIBRIN-FORMING ABILITY, COMPOSITIONS PRODUCED BY THESE PROCESSES, AND THE USE THEREOF | Feb 27, 2019 | Abandoned |
Array
(
[id] => 16539240
[patent_doc_number] => 20200405653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHYLPHENIDATE-CONTAINING TRANSDERMAL PATCH
[patent_app_type] => utility
[patent_app_number] => 16/975827
[patent_app_country] => US
[patent_app_date] => 2019-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975827 | METHYLPHENIDATE-CONTAINING TRANSDERMAL PATCH | Feb 17, 2019 | Abandoned |
Array
(
[id] => 14435283
[patent_doc_number] => 20190175513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => ALL NATURAL, NON-TOXIC SUBLINGUAL DRUG DELIVERY SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/277070
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16277070
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/277070 | ALL NATURAL, NON-TOXIC SUBLINGUAL DRUG DELIVERY SYSTEMS | Feb 14, 2019 | Abandoned |
Array
(
[id] => 16482557
[patent_doc_number] => 20200376157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => HAEMOSTATIC MATERIAL
[patent_app_type] => utility
[patent_app_number] => 16/968710
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968710 | HAEMOSTATIC MATERIAL | Feb 13, 2019 | Pending |
Array
(
[id] => 16482557
[patent_doc_number] => 20200376157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => HAEMOSTATIC MATERIAL
[patent_app_type] => utility
[patent_app_number] => 16/968710
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968710 | HAEMOSTATIC MATERIAL | Feb 13, 2019 | Pending |
Array
(
[id] => 14403519
[patent_doc_number] => 20190167603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Composition for the Transdermal Delivery of Fentanyl
[patent_app_type] => utility
[patent_app_number] => 16/270808
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270808
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270808 | Composition for the Transdermal Delivery of Fentanyl | Feb 7, 2019 | Abandoned |
Array
(
[id] => 14403623
[patent_doc_number] => 20190167655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Transdermal Administration Of Fentanyl And Analogs Thereof
[patent_app_type] => utility
[patent_app_number] => 16/271002
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16271002
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/271002 | Transdermal Administration Of Fentanyl And Analogs Thereof | Feb 7, 2019 | Abandoned |
Array
(
[id] => 14339047
[patent_doc_number] => 20190151496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => NOVEL ACTIVE INGREDIENT IN CICATRIZATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/254211
[patent_app_country] => US
[patent_app_date] => 2019-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16254211
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/254211 | NOVEL ACTIVE INGREDIENT IN CICATRIZATION AND USE THEREOF | Jan 21, 2019 | Abandoned |